Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cimzia in refractory interstitial cystitis
NCT02497976Phase 3Completed
- Start
- Dec 2015
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
A Phase 3 trial of certolizumab pegol in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS). Started Dec 2015; status: completed.
02
Drugs
certolizumab pegol
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on NCT02497976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497976.